Gene Therapy Companies Among Top M&A Targets In 2020

Novo Nordisk And Gilead Tipped To Spend

Zolgensma shows that a gene therapy can be a commercial hit - but there's still plenty to be wary of in this cutting-edge field.

uniQure
UniQure is among the companies tipped for takeover in 2020

The remarkable promise of a single infusion to potentially cure life-limiting diseases has made gene therapy one of the outstanding developments in biopharma in recent years - and big companies have already bought up several pioneers in the field.

The most notable of these was Novartis AG's acquisition of AveXis in April 2018 for $8.7bn, a move which...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Rare Diseases

More from Scrip